Status:
COMPLETED
Non-interventional Study: Real-life Use of Atypical Antipsychotics in Acute Inpatient Management of Schizophrenia
Lead Sponsor:
AstraZeneca
Conditions:
Acute Psychotic Episode
Schizophrenia
Eligibility:
All Genders
18+ years
Brief Summary
This is an observational study describing the real-life antipsychotic treatment during the hospitalisation of the patients due to acute psychotic episode. In this NIS subject's data will be collected...
Detailed Description
RECONNECT-S GAMMA : A non-interventional study to observe real-life usage of atypical antipsychotics in the acute inpatient management of schizophrenia.
Eligibility Criteria
Inclusion
- Written Informed Consent has been obtained from the Subject and/or his/her legal representative (as per local regulatory requirements).
- Meet the diagnostic criteria for schizophrenia stated in The Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV) criteria
- Subject is hospitalised due to an acute psychotic episode
Exclusion
- Current participation in any clinical trial.
- Previous enrolment in the present NIS (in case of recurrence occurred during the enrolment period)
Key Trial Info
Start Date :
December 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2012
Estimated Enrollment :
503 Patients enrolled
Trial Details
Trial ID
NCT01491412
Start Date
December 1 2011
End Date
May 1 2012
Last Update
November 30 2012
Active Locations (14)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Budapest, Hungary
2
Research Site
Debrecen, Hungary
3
Research Site
Győr, Hungary
4
Research Site
Kistarcsa, Hungary